Company Filing History:
Years Active: 2010-2012
Title: Richard M Kinyamu: Innovator in Neurological Treatments
Introduction
Richard M Kinyamu is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of neurology through his innovative methods for treating neurological disorders. With a total of 2 patents, Kinyamu's work focuses on advancing treatment options for conditions affecting the central nervous system.
Latest Patents
Kinyamu's latest patents include groundbreaking methods for treating neurological disorders by the peripheral administration of trophic factors. One of his inventions provides methods for treating subjects with diseases, disorders, or conditions of the central nervous system. These methods involve administering TGF-α polypeptides, related polypeptides, fragments, and mimetics that stimulate progenitor cell or stem cell proliferation, migration, and differentiation. This invention is particularly useful in treating and prophylactically ameliorating neurological tissue injury in vivo.
Another patent by Kinyamu also focuses on treating neurological disorders through the peripheral administration of transforming growth factor alpha (TGF-α). Similar to his previous work, this invention aims to enhance the treatment of central nervous system conditions by utilizing TGF-α polypeptides and their derivatives.
Career Highlights
Kinyamu has established himself as a key figure in the field of neurological research. His innovative approaches have the potential to transform treatment methodologies and improve patient outcomes. His work at Neurorepair, Inc. has positioned him at the forefront of neurological advancements.
Collaborations
Kinyamu collaborates with James H Fallon, contributing to the development of innovative solutions in the field of neurology. Their partnership enhances the research and application of Kinyamu's inventions.
Conclusion
Richard M Kinyamu is a pioneering inventor whose work in neurological treatments is making a significant impact. His patents reflect a commitment to improving the lives of individuals with central nervous system disorders.